- Home
- ICON vs BDRX Comparison
ICON vs BDRX Comparison
Compare ICON & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$2.29
Company Overview
Basic Information| Metric | ICON | BDRX |
|---|---|---|
| Founded | 2023 | 2000 |
| Country | Greece | United Kingdom |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7M | 4.0M |
| IPO Year | 2024 | N/A |
Fundamental Metrics
Financial Performance| Metric | ICON | BDRX |
|---|---|---|
| Price | $0.66 | $2.29 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $4.50 | N/A |
| AVG Volume (30 Days) | 146.8K | ★ 2.8M |
| Earning Date | 04-02-2026 | 09-12-2025 |
| Dividend Yield | ★ 1363.31% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $9,449,000.00 | N/A |
| Revenue This Year | $128.63 | N/A |
| Revenue Next Year | $10.92 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 96.44 | N/A |
| 52 Week Low | $0.55 | $2.32 |
| 52 Week High | $93.19 | $92.00 |
Technical Indicators
Market Signals| Indicator | ICON | BDRX |
|---|---|---|
| Relative Strength Index (RSI) | 35.92 | 37.60 |
| Support Level | $0.55 | $4.55 |
| Resistance Level | $0.77 | $7.22 |
| Average True Range (ATR) | 0.06 | 1.08 |
| MACD | 0.03 | -0.29 |
| Stochastic Oscillator | 39.29 | 0.75 |
Price Performance
Historical Comparison ICON
BDRX
About ICON Icon Energy Corp.
Icon Energy Corp is a growth-oriented shipping company providing seaborne transportation services for dry bulk cargoes via its fleet of oceangoing vessels. The company generates its revenues by chartering its vessels to regional and international dry bulk operators, commodity traders and end users.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.